Skip to main content
Figure 5 | Clinical Epigenetics

Figure 5

From: Epigenetic therapy of acute myeloid leukemia using 5-aza-2'-deoxycytidine (decitabine) in combination with inhibitors of histone methylation and deacetylation

Figure 5

Real-time quantitative PCR analysis of gene expression in AML-3 leukemic cells following sequential treatment with 5-AZA-CdR (A), DZNep (D), and/or TSA (T). The cells were treated with 50 nM 5-AZA-CdR and, at 24 h, 1,000 nM DZNep and/or 40 nM TSA were added to the medium. At 48 h the drugs were removed and at 72 h RNA was isolated for RT-PCR analysis as described in Methods. The relative gene expression is shown as mean ± SEM, n = 3. Statistical analysis for increase in relative expression of: CDKN1A (A), EGR3 (B), FBXO32 (C), CD86 (D), and CDKN2B (F): A + D + T > (A + D, A + T, T + D) P A<0.05 (one way ANOVA). For CDKN1A (A), FBXO32 (C) and SPARC (E): A + D + T > T + D, n.s.

Back to article page